Flow-reversal device for cerebral protection during carotid artery stenting--acute and long-term results

J Interv Cardiol. 2006 Feb;19(1):55-62. doi: 10.1111/j.1540-8183.2006.00105.x.

Abstract

Objective: Several types of cerebral (embolic) protection devices have been used in patients undergoing carotid stenting. This study assessed results achieved with a flow-reversal system.

Method: Carotid stenting was performed in 56 patients (mean age, 68 +/- 9 years). The mean percentage of stenosis was 77%+/- 10%. During the procedure, cerebral protection was achieved by means of balloon occlusion of the common and external carotid artery with use of a Parodi Anti-Emboli System. The patients' neurologic status was assessed during the intervention; at discharge; 1, 6, and 12 months after the procedure; and yearly thereafter.

Results: The procedure was technically successful in all cases. One patient had a minor stroke 6 hours after the intervention. No major strokes, deaths, or myocardial infarctions occurred. During long-term follow-up (to 40 months), 2 patients died of a secondary complication after intracerebral bleeding and stroke and 1 died as a result of ventricular fibrillation. Restenosis did not exceed 50% of vessel diameter in any patient.

Conclusions: The acute results indicate that proximal occlusion and flow reversal for cerebral protection during carotid stenting is a safe and effective method. The low restenosis and complication rate during long-term follow-up is in accordance with other series of carotid angioplasty and shows that the occlusion balloons do not cause any long-term side effects.

Publication types

  • Clinical Trial

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon
  • Blood Vessel Prosthesis Implantation
  • Carotid Artery Diseases / physiopathology
  • Carotid Artery Diseases / therapy*
  • Cerebral Cortex / blood supply*
  • Cerebral Cortex / physiopathology
  • Constriction, Pathologic / physiopathology
  • Constriction, Pathologic / therapy*
  • Female
  • Humans
  • Male
  • Regional Blood Flow
  • Stents / adverse effects*
  • Time Factors